MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS
Clinical trials for MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended safety watch for blood disorder drug
Disease control Recruiting nowThis study aims to understand the long-term safety of the drug luspatercept in people with certain blood disorders. It enrolls about 665 adults who have already participated in other luspatercept trials, either to continue treatment or to be monitored in long-term follow-up. The …
Matched conditions: MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Massive 5,000-Person study launches to map the journey of rare blood cancers
Knowledge-focused Recruiting nowThis is a long-term observational study designed to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. for 5-10 years, collecting health records and patient surveys to track symptoms, treatm…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Apr 02, 2026 05:56 UTC